Enacts provisions relating to cost-sharing for prescription drugs

SB 299 is a bill that aims to establish new rules around cost-sharing for prescription drugs, though specific provisions are not detailed in the available information. It would directly affect patients and potentially healthcare providers by altering how out-of-pocket costs are structured for medications. The bill is currently in the early stages of review, having been referred to the Senate Insurance and Banking Committee after its second reading. No concrete policy mechanisms or affected groups are described in the provided abstract or actions.